Levlite

   
Google
 
Web NewDrugInformation.com

Levlite


Drug - Levlite
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL-28
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ethinyl Estradiol; Levonorgestrel
Multiple ingredients are in alphabetical order.

Strength - 0.02MG;0.1MG
The potency of the active ingredient(s), Ethinyl Estradiol; Levonorgestrel. May repeat for multiple part products.

Applicant - BERLEX
The firm name holding legal responsibility for Levlite. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020860
The FDA assigned number to Levlite. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Levlite. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB2
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jul 13, 1998
The date Levlite was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Levlite. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Levlite is in. Format is RX, OTC, DISCN.

Applicant Full Name - Berlex Inc
The full name of the firm holding legal responsibility for the new application of Levlite.

Levlite